Literature DB >> 17032887

Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem.

Eric J Feuer1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17032887     DOI： 10.1093/jncimonographs/lgj002

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN： 1052-6773


× No keyword cloud information.
  14 in total

Review 1.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Tumour doubling times and the length bias in breast cancer screening programmes.

Authors:  Israel T Vieira; Valter de Senna; Paul R Harper; Arjan K Shahani
Journal:  Health Care Manag Sci       Date:  2011-03-29

3.  The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Patrick L Remington
Journal:  Cancer Causes Control       Date:  2010-11-16       Impact factor: 2.506

4.  Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality.

Authors:  Thomas J Hoerger; Donatus U Ekwueme; Jacqueline W Miller; Vladislav Uzunangelov; Ingrid J Hall; Joel Segel; Janet Royalty; James G Gardner; Judith Lee Smith; Chunyu Li
Journal:  Am J Prev Med       Date:  2011-04       Impact factor: 5.043

5.  Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.

Authors:  Oguzhan Alagoz; Donald A Berry; Harry J de Koning; Eric J Feuer; Sandra J Lee; Sylvia K Plevritis; Clyde B Schechter; Natasha K Stout; Amy Trentham-Dietz; Jeanne S Mandelblatt
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

6.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.

Authors:  Brian L Sprague; Natasha K Stout; Clyde Schechter; Nicolien T van Ravesteyn; Mucahit Cevik; Oguzhan Alagoz; Christoph I Lee; Jeroen J van den Broek; Diana L Miglioretti; Jeanne S Mandelblatt; Harry J de Koning; Karla Kerlikowske; Constance D Lehman; Anna N A Tosteson
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

7.  Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia.

Authors:  Jeroen J van den Broek; Nicolien T van Ravesteyn; Eveline A Heijnsdijk; Harry J de Koning
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

8.  Breast cancer incidence and overdiagnosis in Catalonia (Spain).

Authors:  Montserrat Martinez-Alonso; Ester Vilaprinyo; Rafael Marcos-Gragera; Montserrat Rue
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

9.  Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information.

Authors:  James F O'Mahony; Joost van Rosmalen; Ann G Zauber; Marjolein van Ballegooijen
Journal:  Med Decis Making       Date:  2012-08-27       Impact factor: 2.583

10.  Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).

Authors:  Misericordia Carles; Ester Vilaprinyo; Francesc Cots; Aleix Gregori; Roger Pla; Rubén Román; Maria Sala; Francesc Macià; Xavier Castells; Montserrat Rue
Journal:  BMC Cancer       Date:  2011-05-23       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.